TL;DR: CureMD's FHIR and HL7 APIs are the right choice when the data you need is already structured and lives in a system that also has an API. AI agents that operate the CureMD interface are the right choice when records arrive as faxes, PDFs, and portal downloads that no API will ever hand you cleanly. Most practices evaluating CureMD patient data fetching automation need both, and the sequencing question — which one first — is settled by looking at what's actually in your fax queue.
What's actually different about the two approaches
Both approaches end in the same place: a record lands in the right patient's chart in CureMD without a staff member typing it. They get there by completely different means, and the difference isn't a matter of technical taste.
An API integration is a contract. Two systems agree on a format, a connection gets built and tested, and structured data flows between them. CureMD supports this through FHIR and HL7 interfaces. When the pipe exists, it's fast, exact, and quiet. Nobody thinks about it again.
An AI agent is a worker. It has credentials, it opens the source system and CureMD the way a person does, it reads what's on the screen or in the document, and it makes a decision about what the thing is and where it goes. It doesn't need the other side to agree to anything, because it isn't asking.
That single distinction drives everything else. An API requires cooperation from the source. An agent doesn't. Which means the question isn't really "which technology is better" — it's "does the source of my records have an API, and will they give me access to it?"
For lab interfaces and HIE connections, usually yes. For the imaging center across town, the referring practice that still faxes, and the hospital portal you log into with a shared password, no. Not this year and probably not next.
Which data formats are you actually receiving?
Go look at what came in last week. This one observation decides the question faster than any vendor comparison.
Sort your inbound records into two buckets:
- Already structured somewhere. Lab results from a reference lab with an interface. Eligibility responses from a payer. Clinical summaries available through an HIE query. These have a machine-readable form on the other end, even if you're currently reading them as a printout.
- Only ever a document. Faxed referral packets. PDFs downloaded from a facility portal. Operative reports sent as an attachment. Records that arrive on a disc. There's no structured version of these anywhere, because the source never made one.
The ratio between those two buckets is your answer. If 80% of your volume is in the second bucket — and for most independent practices it is — then API work, however well executed, leaves 80% of the problem untouched.
ONC's national data on health information exchange makes the pattern visible: only about 24% of independent physicians report that outside information is actually integrated into their EHR, against 38–40% of physicians at larger and health-system-affiliated practices. Health systems have more interfaces because they have more pull with the organizations they connect to. Independent practices don't, and no amount of integration budget changes that.
There's a second sorting question worth asking alongside the first: which of these documents is blocking something? A lab result that arrives a day late is a minor annoyance. A prior authorization approval or a referral packet that arrives late cancels a visit. Rank your two buckets by that consequence as well as by volume, because the highest-consequence documents are almost always in the second bucket — the ones that only ever exist as paper.
What does each approach cost to build and maintain?
The build cost is the number vendors quote. The maintenance cost is the one that determines whether you regret the decision in year three.
API integration. Build cost is engineering time on both sides, plus testing, plus whatever the source charges for interface access — some labs and hospitals charge per connection. Maintenance cost is low but nonzero: version changes, certificate renewals, occasional schema updates. The real cost is opportunity cost. Every new source is a new project, and the project queue only grows.
AI agents. Build cost is configuration rather than code — credentials, filing rules, and a supervised validation period. Maintenance cost is monitoring: sources change their interfaces, and the agent has to adapt. A well-run agent platform absorbs that on the vendor side; a poorly-run one hands you the breakage.
Set against either is the cost of doing nothing, which is staffing. The 2026 MGMA Regulatory Burden Report found 40% of practices carry three or more full-time administrative staff per physician on regulatory and payer work. Records retrieval is a real share of that, and it's the share that scales linearly with visit volume. Neither automation approach is expensive compared to adding an FTE every time you add a provider.
How does each one break?
Both fail. They fail differently, and the difference matters for how you staff around them.
APIs fail loudly and completely. A connection drops, a certificate expires, a schema changes — and nothing comes through. You notice, because the absence is total. Someone fixes it. During the outage you're back to manual, which is unpleasant but familiar.
Agents fail quietly and partially. An agent might misclassify one document type after a source redesigns its forms, while everything else keeps flowing. That's harder to notice and easier to live with for too long. It's also why the supervised validation window and the permanent sample review aren't optional — they're how you catch the partial failure.
There's a third failure mode worth naming, and it belongs to agents: confident errors. An agent that files a document to the wrong patient does so with the same certainty as a correct filing. Require configurable confidence thresholds and mandatory escalation on ambiguous patient matches. A tool that never escalates isn't confident, it's unsupervised.
The staffing implication is different for each. An API outage is a temporary return to the manual process your team already knows, so the recovery plan is "do it the old way for a day." Agent drift needs someone whose job includes looking at a weekly accuracy sample. That's maybe an hour a week, but it has to be assigned to a named person, because a review nobody owns stops happening by the third month.
Where each approach genuinely falls short
Neither side should be sold to you without these.
The honest weakness of APIs is scope. An interface can only deliver what's already structured on the other end, and most of the records a practice chases have no structured form. Interface projects also take months and depend on a counterparty with no particular urgency. Teams routinely spend eight months on integration work and still have a full fax queue at the end of it — not because the work was done badly, but because the work never addressed the documents.
The honest weakness of agents is that they're reading, and reading can be wrong. A poor-quality fax, an unfamiliar form layout, or a document that genuinely requires clinical judgment will produce errors. They need a supervised period before you trust them, they need exception routing, and they need somebody watching the accuracy numbers. Anyone who tells you an agent runs at 100% is not describing a real deployment.
Honey Health's Data Fetching agent sits on the agent side of this line, and the reason practices pick that route is usually specific: they have records sitting behind portals and fax lines that nobody is going to build an interface for. That's the problem agents solve. It isn't the problem APIs solve, and pretending otherwise helps nobody.
A decision rule you can use this week
Skip the vendor matrix. Answer three questions.
- What share of your inbound record volume is documents rather than structured data? Count last week. If it's over half, agents address the bigger half of your problem and should come first.
- Do you have engineering capacity you control? Not a vendor's engineers — yours, or a contractor you can direct. If not, interface projects will stall in a queue you can't influence, regardless of merit.
- What's your time horizon? If you need relief this quarter, agents deploy in weeks. If the pain is tolerable and you're building for three years out, an interface for your top-volume structured source is a durable investment.
The common landing spot: interfaces for labs and eligibility, agents for everything arriving as a document, sequenced so the agent work goes first because it clears the bigger pile faster. Treating this as a single either-or decision is the most frequent mistake, and it usually results in one approach being over-applied to data it was never suited for.
One caveat on sequencing. If you already have an interface project half-built and funded, finish it. Half-built integrations are pure cost with no return, and abandoning one to chase a different approach wastes the money twice. Sequence the next decision by the rule above, not the one already in flight.
Frequently Asked Questions
Can AI agents and API integrations run at the same time in CureMD?
Yes, and most mature setups do. They write to different parts of the chart through different mechanisms and don't conflict. The one thing to coordinate is deduplication — if a lab result arrives through both an interface and a faxed report, define which one wins so you don't end up with the same result filed twice.
Is an API integration more secure than an AI agent?
Not inherently. Both handle PHI and both should be governed the same way: a signed BAA, encryption in transit and at rest, role-based access, and a complete audit log of every action taken. Ask for an agent's audit trail specifically — you want a record of which document it read and where it filed it, not just that it ran.
Which approach handles faxes better?
Agents, by a wide margin. Faxes arrive as images with no structured data behind them, so there's nothing for an API to transmit. Getting a fax into a chart requires reading the document, classifying it, and matching it to a patient — which is judgment work, not transport.
Does CureMD charge for API access?
Interface terms vary by contract and by what you're connecting to, so treat pricing as a question for your CureMD account team rather than something to assume. Budget for the source side too: some labs, hospitals, and imaging centers charge their own fees for interface connections.
What if we build an API integration and the source changes their format?
You rebuild or patch it, and you're down until that's done. This is the standard maintenance burden of interface work and it's manageable when you have a handful of connections. It becomes the argument for agents once you're maintaining twenty, since the per-connection fragility compounds.
